MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
Tourmaline Bio, Inc. (NASDAQ:TRML)*
Organization & Developments: Tourmaline Bio
Parents
Tourmaline Bio, Inc. (NASDAQ:TRML)*
Children
* The company potentially possesses a best-in-class therapy for both thyroid eye and atherosclerotic cardiovascular diseases
2023: Tourmaline Bio: Time For A Pause_seekingalpha.com
2024: Tourmaline Bio forms Cardiovascular Scientific Advisory Board
2024: Tourmaline Bio, Talaris Therapeutics Announce Reverse Merger in Stock Deal
2024: Tourmaline Bio: Looking To Go Beyond FcRn Inhibition With IL-6 Targeting
2024: Tourmaline Bio: Sinking On Rival's Stodgy Data - I'm Slightly Bearish
2025: Tourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 Inhibition
Jumps
Finance & Acquisitions: Tourmaline Bio
Key People: Tourmaline Bio